CVE-2023-20223

Description

A vulnerability in Cisco DNA Center could allow an unauthenticated, remote attacker to read and modify data in a repository that belongs to an internal service on an affected device. This vulnerability is due to insufficient access control enforcement on API requests. An attacker could exploit this vulnerability by sending a crafted API request to an affected device. A successful exploit could allow the attacker to read and modify data that is handled by an internal service on the affected device.

Category

8.6
CVSS
Severity: High
CVSS 3.1 •
EPSS 0.17%
Vendor Advisory cisco.com
Affected: Cisco Cisco Digital Network Architecture Center (DNA Center)
Published at:
Updated at:

References

Link Tags
https://sec.cloudapps.cisco.com/security/center/content/CiscoSecurityAdvisory/cisco-sa-dnac-ins-acc-con-nHAVDRBZ vendor advisory

Frequently Asked Questions

What is the severity of CVE-2023-20223?
CVE-2023-20223 has been scored as a high severity vulnerability.
How to fix CVE-2023-20223?
To fix CVE-2023-20223, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2023-20223 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2023-20223 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2023-20223?
CVE-2023-20223 affects Cisco Cisco Digital Network Architecture Center (DNA Center).
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.